Call Support +91-85588-96644
TCYonline

Login

Sign Up

Please enter a Username or Email ID
Please enter a password
Keep me logged in
Please enter your name
Please enter your mobile number
You can't leave Captcha Code empty
By submitting this form, you agree to the Terms & Privacy Policy.
OR

Sign Up via Facebook

Sign Up via Google

Sign Up via Twitter

Download Software
Tests given

Download TCY App

App Image
 
loading

SCIENCE & TECHNOLOGY - July 2025

Jul 2025

Jan 15, 2026

MeitY organises BHASHINI Samudaye workshop to strengthen language AI

The Ministry of Electronics and Information Technology hosted the BHASHINI Samudaye workshop in New Delhi to enhance India’s language AI ecosystem under the National Language Translation Mission. The Digital India BHASHINI Division brought together language experts, academia, civil society, and data practitioners to co-create and govern language AI solutions. Discussions covered scaling BHASHINI, platform roadmaps, data governance, and long-term collaboration to ensure inclusive public services. The event showcased examples like BhashaDaan and highlighted responsible data practices while seeking partnerships with states and institutions to advance multilingual governance and education through AI.
  • BHASHINI Samudaye workshop organized by MeitY
  • Focus on strengthening language AI under NLTM
  • Participants include language experts, academia, civil society
  • Discussions on scaling BHASHINI and data governance

Jan 14, 2026

Sentynl drug for Menkes disease gains U.S. FDA nod

Sentynl Therapeutics, a Zydus Lifesciences subsidiary, received U.S. FDA approval for Zycubo (copper histidinate) to treat Menkes disease in paediatric patients. This marks the first and currently the only approved treatment for a rare, fatal genetic disorder affecting copper metabolism in children. Zydus stated that the approval could offer a critical therapeutic option for affected families and may stimulate further research into metabolic disease management. The development highlights ongoing biopharmaceutical innovation and the global interest in rare disease therapies.
  • FDA approves Zycubo (copper histidinate) for Menkes disease
  • First and only approved treatment in the U.S.
  • Significant milestone for Sentynl and Zydus Lifesciences
  • Potential impact on rare disease management
  • Could spur further research in metabolic disorders

KAIST researchers reprogram tumor immune cells to fight cancer

Researchers at KAIST developed a method to reprogram immune cells inside tumors into cancer-fighting agents. A drug injected directly into the tumor is taken up by macrophages, prompting them to attack cancer cells and activate nearby immune responses. This approach avoids lab-based cell extraction and modification. In animal models, the strategy slowed tumor growth and elicited strong anticancer immune activity. The team, led by Professor Ji-Ho Park, believes the technique could offer a new pathway for treating solid tumors and could complement existing therapies in humans after further testing.
  • KAIST method reprograms tumor macrophages to attack cancer
  • Direct intratumoral drug activates immune response
  • No need for ex vivo cell manipulation
  • Shown to slow tumor growth in animal models
  • Potential new avenue for solid tumor therapies

Jan 13, 2026

ISRO to launch PSLV-C62 with EOS-N1 mission on January 12, 2026

ISRO announced the PSLV-C62 mission, set for 12 January 2026 at 10:17 IST from Sriharikota. The primary payload is EOS-N1, also called Anvesha, an Earth observation satellite developed for DRDO. The mission will carry 18 co-passenger satellites from domestic and international partners. The launch marks India’s first space mission of 2026 and the 64th PSLV flight. The mission will bolster remote sensing capabilities for agriculture, urban planning, and environmental monitoring. Observers view PSLV-C62 as a milestone that demonstrates India’s growing capabilities in space science and global collaboration in satellite ventures.
  • PSLV-C62 launch scheduled for 12 January 2026, 10:17 IST.
  • Primary payload EOS‑N1 (Anvesha) for DRDO.
  • 18 co-passenger satellites from multiple partners aboard.
  • First ISRO launch of 2026; 64th PSLV flight.
  • Supports remote sensing for agriculture, urban mapping, environment.

Meta to power AI data centres with 6.6 GW of US nuclear power by 2035

Tech giant Meta announced agreements with three U.S. nuclear energy companies to supply up to 6.6 gigawatts of clean power by 2035 for its artificial intelligence data centres. The deals position Meta as one of America’s largest corporate buyers of nuclear energy and align with its strategy to run AI workloads on low-emission electricity. The arrangement supports Meta’s data centre expansion and sustainability goals, reducing carbon emissions while enabling faster processing capabilities for large-scale AI tasks. The partnerships reflect growing industry use of nuclear energy in extensive data operations.
  • Meta signs power deals for up to 6.6 GW of nuclear energy by 2035.
  • Power supports AI data centres; aims for low-emission electricity.
  • Positions Meta among top US corporate buyers of nuclear energy.
  • Supports expansion of AI workloads with sustainable power.
  • Signals broader industry shift to nuclear energy for data needs.

Jan 11, 2026

Raisina Science Diplomacy Initiative launched for 2026

India announced the Raisina Science Diplomacy Initiative (RSDI) 2026 to strengthen the interface between science, technology, and diplomacy. This institutional effort aims to embed science diplomacy within India’s Raisina Dialogue framework. The initiative is a collaborative project between the Office of the Principal Scientific Adviser to the Government of India and the Observer Research Foundation. RSDI seeks to create a dedicated platform during the Raisina Dialogue to discuss how science and technology influence international relations, policy making, and global collaboration. The move reflects India’s emphasis on using science to advance strategic diplomacy and international partnerships.
  • RSDI 2026 announced to integrate science diplomacy with Raisina Dialogue.
  • Joint effort by the Prime Scientific Adviser’s office and ORF.
  • Aims to host a dedicated platform within Raisina Dialogue.
  • Focus on science, technology, and diplomacy in policy discourse.

Jan 10, 2026

MeitY launches Param Shakti at IIT Madras, hosting PARAM RUDRA system

MeitY Secretary S. Krishnan inaugurated Param Shakti at IIT Madras in January 2026, hosting the indigenous PARAM RUDRA system. The facility, developed by C‑DAC under the National Supercomputing Mission, runs on open-source software and delivers a peak performance of 3.1 petaflops. Param Shakti strengthens India’s self-reliant high-performance computing ecosystem, with NSM aiming to scale up national capacity through additional systems nationwide. Researchers will apply the system across domains such as aerospace, materials science, climate modelling, drug discovery, and advanced manufacturing, accelerating simulations and reducing dependence on external technologies.
  • Param Shakti housed at IIT Madras; inaugurated January 2026
  • 3.1 petaflops peak performance with PARAM RUDRA
  • Indigenous system; built under NSM by C‑DAC
  • Open-source software; strengthens India’s HPC ecosystem
Share on
Keep Yourself updated on Latest PTE Exam Pattern

Avail Free Topic-wise Tests and various other offers.